MedTrace Logo

Preventing Chemotherapy-induced Peripheral Neuropathy Using PRESIONA Exercise Program

NCT04652609 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2025-11-18

No results posted yet for this study

Summary

The aim of this study is to determinate if therapeutic exercise with blood flow restriction (BFR) during neoadjuvant chemotherapy potentialy neurotoxic could prevent the onset of chemotherapy induced peripheral neuropathy (CIPN) comparing to usual care.

Conditions

  • Breast Neoplasm

Interventions

OTHER

PRESIONA

Aerobic and strength exercise combined with restricction blood flow cuffs during chemotherapy treatment

Sponsors & Collaborators

  • Universidad de Granada

    lead OTHER

Principal Investigators

  • Irene Cantarero-Villanueva, PhD · Physical Therapy Deparment, Faculty of Health Sciences, University of Granada

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2025-01-01
Completion
2027-01-01

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04652609 on ClinicalTrials.gov